Phase II trials of trimetrexate in advanced adult soft tissue sarcoma
- 1 October 1991
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (9) , 689-690
- https://doi.org/10.1093/oxfordjournals.annonc.a058051
Abstract
E. A. Eisenhauer, R. Wierzbicki, M. Knowling, V. H. C. Bramwell, I. C. Quirt; Short report: Phase II trials of trimetrexate in advanced adult soft tissue sarcoKeywords
This publication has 3 references indexed in Scilit:
- Trimetrexate: Predictors of Severe or Life-Threatening Toxic EffectsJNCI Journal of the National Cancer Institute, 1988
- Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitroBiochemical Pharmacology, 1984
- Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminoquinazolines and related compoundsJournal of Medicinal Chemistry, 1974